Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

During the Trading Day
378.80 +1.37 / +0.36%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
379.97 +1.17 / +0.31%
 
Volume: 72.9K

Investment Objective

The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.

Performance

1 month+4.57% 3 years+40.20%
3 months+9.56% 5 years+36.87%
1 year+48.29% Since inception+9.76%
Data through 07/30/2015

Quote Details

Previous close$377.43
Open day’s range370.30 – 380.14
Net asset value (NAV)377.60 (07/29/2015)
Daily volume1,566,944
Average volume (3 months)1,662,325
Data as of 4:14pm ET, 07/30/2015

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+36.87%+26.72%
Expense Gross exp ratio0.48%0.47%
Risk 5 year sharpe ratio1.921.74
Net assets$9.0B$2.0B
Average market cap$21.1B$37.5B
Average P/E27.525.5
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences8.24%
BIIB Biogen8.04%
CELG Celgene7.99%
AMGN Amgen7.77%
REGN Regeneron Pharmaceuticals7.08%
ALXN Alexion Pharmaceuticals Inc4.36%
ILMN Illumina Inc4.19%
VRTX Vertex Pharmaceuticals Inc3.80%
MYL Mylan NV3.69%
BMRN Biomarin Pharmaceutical Inc3.14%